NCT03823118 2023-02-23S1 Plus Anlotinib in Treating Patients With Refractory or Relapsed Small-cell Lung CancerTaizhou HospitalPhase 2 Completed48 enrolled
NCT02477813 2018-11-13TeResIstituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSPhase 2 Terminated6 enrolled